Back

CME Outfitters, LLC

  • Diabetes Mellitus, Type 2
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Glycemic Control
  • Palliative Care
  • Renal Insufficiency, Chronic

From Data to Decisions: Real-World Case Studies in Personalized GLP-1 RA Therapy for T2D

GLP-1 receptor agonists (GLP-1 RAs) are revolutionizing glycemic control for patients with type 2 diabetes (T2D), but with rising clinical complexity and diverse patient needs, a one-size-fits-all approach is insufficient. While every currently available GLP-1 RA is indicated for blood sugar management in patients with T2D, emerging evidence shows that certain agents offer distinct advantages particularly for patients with cardiovascular disease (CVD), chronic kidney disease (CKD), or a mix of comorbidities. This critical data frequently remains untapped in real-world treatment plans, however, resulting in missed opportunities to deliver the most effective, personalized care. Clinicians and multidisciplinary care teams need next-level education that translates robust clinical trial evidence into targeted, patient-first decisions, maximizing the therapeutic potential of each GLP-1 RA and elevating outcomes across the T2D population. In the third activity of this CME Outfitters Snack series, expert faculty will incorporate clinical trial evidence supporting the use of GLP-1 RAs in T2D management, including outcomes related to glucose control, CV safety, CKD, and tolerability. Faculty will model utilization of current treatment guidelines to implement GLP-1 RA therapy tailored to individual patient characteristics, including comorbidities, goals of care, and lifestyle considerations.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.75 creditsAMA PRA Category 1 Credit™Up to 0.75 creditsNursingUp to 0.75 creditsPharmacyUp to 0.75 credits

MOC types

ABIM — Medical KnowledgeUp to 0.75 points

FDA REMS

No

Qualifies for MIPS

Yes

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.75 credits
  • MOC · Up to 0.75 points
  • Commercial Support
  • Released
    Sep 11, 2025
  • Last day to claim credit
    Nov 1, 2026 3 weeks left